Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Sprog
Alle Felter
Titel
Forfatter
Fag
Klassifikationsnummer
ISBN/ISSN
Tag
Find
Udvidet
Cetuximab plus Irinotecan as t...
Citér dette
Stav dette
Email dette
Udskriv
Eksportér post
Eksportér til RefWorks
Eksportér til EndNoteWeb
Eksportér til EndNote
Permanent link
Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
Bibliografiske detaljer
Main Authors:
Moe, M
,
Micallef, R
,
Pwint, T
,
Maughan, T
,
Mort, D
,
Wagstaff, J
Format:
Journal article
Udgivet:
2008
Beholdninger
Beskrivelse
Lignende værker
Medarbejdervisning
Lignende værker
Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis
af: Meysam Seyedifar, et al.
Udgivet: (2024-10-01)
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
af: Frifeldt Sanne K, et al.
Udgivet: (2011-03-01)
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
af: Maria Ignez Freitas Melro Braghiroli, et al.
Udgivet: (2024-01-01)
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
af: Adams, R, et al.
Udgivet: (2008)
First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
af: Yu‐Wen Zhou, et al.
Udgivet: (2021-05-01)